Early complement activation increases in the brain in some aged normal subjects

Complement activation is increased in Alzheimer’s disease (AD) and may contribute to the development and progression of this disorder. To compare early complement activation between normal and AD brain specimens, C4d and iC3b concentrations were measured in hippocampus, entorhinal cortex, temporal c...

Full description

Saved in:
Bibliographic Details
Published in:Neurobiology of aging Vol. 25; no. 8; pp. 1001 - 1007
Main Authors: Loeffler, David A, Camp, Dianne M, Schonberger, Michael B, Singer, Daniel J, LeWitt, Peter A
Format: Journal Article
Language:English
Published: London Elsevier Inc 01-09-2004
Elsevier Science
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Complement activation is increased in Alzheimer’s disease (AD) and may contribute to the development and progression of this disorder. To compare early complement activation between normal and AD brain specimens, C4d and iC3b concentrations were measured in hippocampus, entorhinal cortex, temporal cortex, parietal cortex, and cerebellum from aged normal and AD subjects ( n=10–14 for both), and in hippocampus and entorhinal cortex from younger normal subjects ( n=5–6). C4d and iC3b levels increased 2.3- to 4.6-fold in AD versus aged normal specimens (all P<0.05), with lowest concentrations of these activation proteins generally in cerebellum. No significant differences were present between aged and younger normal C4d and iC3b levels in hippocampus or entorhinal cortex. However, the concentrations of these proteins were markedly increased in several aged normal specimens. Normal subject age was moderately associated with both C4d ( r=0.49) and iC3b ( r=0.53) concentrations in the hippocampus. Increased brain complement activation in some elderly individuals may promote the subsequent development of AD.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0197-4580
1558-1497
DOI:10.1016/j.neurobiolaging.2003.11.003